Suppr超能文献

HLA-DQB1第一结构域氨基酸序列与硬皮病(进行性系统性硬化症)中抗拓扑异构酶I自身抗体反应的关联

Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis).

作者信息

Reveille J D, Durban E, MacLeod-St Clair M J, Goldstein R, Moreda R, Altman R D, Arnett F C

机构信息

Department of Internal Medicine, University of Texas Health Science Center, Houston 77225.

出版信息

J Clin Invest. 1992 Sep;90(3):973-80. doi: 10.1172/JCI115974.

Abstract

Previous studies in Caucasians with progressive systemic sclerosis (PSS) have suggested associations of antitopoisomerase I (antitopo I) autoantibodies with either serologically defined HLA-DR2 or DR5. To better define class II HLA associations with the antitopo I response, 161 PSS patients (132 Caucasians and 29 American blacks) were studied for antitopo I autoantibodies by immunodiffusion and immunoblotting, and their HLA-DRB1, DRB3, DQA1, and DQB1 alleles were determined by restriction fragment length polymorphic analysis and DNA oligotyping. Among Caucasians with antitopo I, HLA-DR5(DRB11101-1104), DRB30202 and DQw3 (DQw7,8,9) were significantly increased in frequency. In American blacks, however, only HLA-DQB10301(DQw7) was significantly increased. The presence of HLA-DQB10301(DQw7) and other HLA-DQB1 alleles bearing the uncharged polar amino acid residue tyrosine at position 30 of the outermost domain was found in all antitopo I-positive Caucasian PSS patients compared with 66% of antitopo I-negative PSS patients (pc = 0.007) and 70% of normal controls (pc = 0.008), as well as all antitopo I-positive black patients. The association with HLA-DQB1 was independent of HLA-DR5(DRB11101-*1104) or any other HLA-DRB1, DRB3, or DQA1 alleles. Alternative or additional candidate epitopes for this autoimmune response include alanine at position 38 and threonine at position 77 of these same DQB1 alleles. These data suggest that genetic predisposition to the antitopo I response in PSS is associated most closely with the HLA-DQB1 locus.

摘要

先前针对患有进行性系统性硬化症(PSS)的高加索人的研究表明,抗拓扑异构酶I(抗拓扑I)自身抗体与血清学定义的HLA - DR2或DR5有关联。为了更好地确定II类HLA与抗拓扑I反应的关联,对161例PSS患者(132例高加索人和29例美国黑人)进行了免疫扩散和免疫印迹法检测抗拓扑I自身抗体,并通过限制性片段长度多态性分析和DNA寡核苷酸分型法确定了他们的HLA - DRB1、DRB3、DQA1和DQB1等位基因。在具有抗拓扑I的高加索人中,HLA - DR5(DRB11101 - 1104)、DRB30202和DQw3(DQw7、8、9)的频率显著增加。然而,在美国黑人中,只有HLA - DQB10301(DQw7)的频率显著增加。在所有抗拓扑I阳性的高加索PSS患者中,均发现了HLA - DQB10301(DQw7)以及在最外层结构域第30位带有不带电荷的极性氨基酸残基酪氨酸的其他HLA - DQB1等位基因,相比之下,抗拓扑I阴性的PSS患者中有66%(pc = 0.007)以及正常对照中有70%(pc = 0.008)具有这些等位基因,并且所有抗拓扑I阳性的黑人患者也都具有。与HLA - DQB1的关联独立于HLA - DR5(DRB11101 - *1104)或任何其他HLA - DRB1、DRB3或DQA1等位基因。这种自身免疫反应的替代或额外候选表位包括这些相同DQB1等位基因第38位的丙氨酸和第77位的苏氨酸。这些数据表明,PSS中抗拓扑I反应的遗传易感性与HLA - DQB1基因座关系最为密切。

相似文献

引用本文的文献

4
Systemic sclerosis in Asians: Are there racial differences?亚洲人的系统性硬化症:存在种族差异吗?
J Scleroderma Relat Disord. 2022 Jun;7(2):98-109. doi: 10.1177/23971983221074749. Epub 2022 Feb 3.
5
Updates on genetics in systemic sclerosis.系统性硬化症遗传学的最新进展。
Inflamm Regen. 2021 Jun 15;41(1):17. doi: 10.1186/s41232-021-00167-6.
8
Current perspectives on the immunopathogenesis of systemic sclerosis.系统性硬化症免疫发病机制的当前观点
Immunotargets Ther. 2016 Apr 11;5:21-35. doi: 10.2147/ITT.S82037. eCollection 2016.

本文引用的文献

1
Skin manifestations of pentazocine abuse.喷他佐辛滥用的皮肤表现。
J Am Acad Dermatol. 1980 Jan;2(1):47-55. doi: 10.1016/s0190-9622(80)80292-1.
4
Increased frequency of HLA-DR5 in scleroderma.硬皮病中HLA - DR5频率增加。
Arthritis Rheum. 1981 Jun;24(6):854-6. doi: 10.1002/art.1780240614.
7
HLA antigens and scleroderma.人类白细胞抗原(HLA)抗原与硬皮病
Arch Dermatol Res. 1981;271(4):381-5. doi: 10.1007/BF00406682.
9
Increased prevalence of DRw3 in the CREST syndrome.在CREST综合征中DRw3的患病率增加。
Arthritis Rheum. 1981 Jun;24(6):857-9. doi: 10.1002/art.1780240615.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验